Medical device maker DexCom announced Tuesday that the company has received a de novo clearance from the FDA to sell its latest continuous glucose monitoring system — the G6 — that requires no ...

San Diego’s Dexcom posted a 30 percent jump in revenue for the March quarter as it prepares for a major launch of its next generation continuous glucose monitors that no longer requires finger pricks ...